CardioVascular BioTherapeutics, Inc. 4
4 · CardioVascular BioTherapeutics, Inc. · Filed Jan 24, 2008
Insider Transaction Report
Form 4
Priemer Wolfgang
Director
Transactions
- Sale
Common Stock
2008-01-24$1.15/sh−5,000$5,750→ 14,935,000 total(indirect: WOBEMA, BV as Director)
Holdings
- 1
Common Stock
Footnotes (1)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan as of 9/10/07 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.